BioVie Inc.
BIVI · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $9 | $23 | $33 | $17 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $9 | $0 | $12 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $9 | $0 | $10 |
| Operating Expenses | $18 | $32 | $45 | $27 |
| Operating Income | -$18 | -$32 | -$45 | -$27 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1 | $0 | -$5 | $1 |
| Pre-Tax Income | -$18 | -$32 | -$50 | -$26 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$18 | -$32 | -$50 | -$26 |
| % Margin | – | – | – | – |
| EPS | -12.12 | -73.05 | -154.7 | -106 |
| % Growth | 83.4% | 52.8% | -45.9% | – |
| EPS Diluted | -12.12 | -73.05 | -154.7 | -106 |
| Weighted Avg Shares Out | 1 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 1 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $0 |
| Interest Expense | $0 | $3 | $4 | $2 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$17 | -$32 | -$46 | -$27 |
| % Margin | – | – | – | – |